603309 维力医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.90210.87210.0887.82214.170
总资产报酬率 ROA (%)3.9437.7177.3775.86010.400
投入资产回报率 ROIC (%)4.4828.9248.5126.73411.850

边际利润分析
销售毛利率 (%)45.07045.88943.19242.36143.755
营业利润率 (%)19.57117.21115.15812.75917.535
息税前利润/营业总收入 (%)19.48417.46314.89613.39218.438
净利润/营业总收入 (%)16.35614.74413.03810.25214.140

收益指标分析
经营活动净收益/利润总额(%)95.04796.498101.525101.623107.841
价值变动净收益/利润总额(%)2.9153.6282.914-0.592-0.942
营业外收支净额/利润总额(%)-0.824-0.647-0.486-1.780-4.290

偿债能力分析
流动比率 (X)1.7231.8532.0822.2851.822
速动比率 (X)1.4291.5281.7411.8901.263
资产负债率 (%)35.48229.49327.01225.36523.162
带息债务/全部投入资本 (%)24.97616.44613.19211.894--
股东权益/带息债务 (%)287.380489.571635.190714.814820.389
股东权益/负债合计 (%)180.449236.488267.743291.841328.907
利息保障倍数 (X)268.74948.163-79.06715.64911.355

营运能力分析
应收账款周转天数 (天)51.49836.58329.87636.7620.000
存货周转天数 (天)76.56173.36877.00784.2480.000